ABL Bio secures major $3.4 billion technology transfer deal with GSK for 'Grabody-B' drug development platform, marking second-largest biotech agreement in South Korea
#YonhapInfomax #ABLBio #GlaxoSmithKline #TechnologyTransfer #GrabodyB #BiotechIndustry #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=57545
